Similarly, MS023 exposure induced apoptosis in CML CD34+CD38− cells, without an additive or synergistic effect when co‐treated with imatinib (Figure S1B,C, Supporting Information). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.